A Retrospective cohort study comparing Rivaroxaban versus Warfarin in patients hospitalized for Venous Thromboembolism (VTE)

Trial Profile

A Retrospective cohort study comparing Rivaroxaban versus Warfarin in patients hospitalized for Venous Thromboembolism (VTE)

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Rivaroxaban (Primary) ; Warfarin
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2016 Results (n=1502) of a subgroup analysis comapring hospital LOS and costs in patients with a primary diagnosis of PE were published in the Clinical Therapeutics
    • 06 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top